ÂÜÀòÂÒÂ×

Antonio Julià, PhD, has over 18 years’ experience in the generation and analysis of high-throughput omic data in immune-mediated inflammatory diseases (IMIDs). He received a BA in Biology and PhD in Molecular Biology from the Autonomous University of Barcelona. Dr Julià is currently the head of the Rheumatology Research Group at the Vall d’Hebron Research Institute in Barcelona (Spain). He has led the first genome-wide association studies in immune-mediated inflammatory diseases in a Southern European population, identifying new susceptibility genes and associated biological pathways. Toni has a large experience in translational research in IMIDs, authoring several studies in this area, and is co-inventor of granted patents on treatment individualization. He has developed several bioinformatic approaches for the analysis of high-throughput data, improving state-of-the-art methods.